TWD 744.0
(-0.67%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 25.05 Billion TWD | 10.06% |
2022 | 22.76 Billion TWD | 208.74% |
2021 | 7.37 Billion TWD | 5.26% |
2020 | 7 Billion TWD | 107.06% |
2019 | 3.38 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 30.65 Billion TWD | 22.38% |
2024 Q2 | 43.35 Billion TWD | 41.4% |
2023 Q4 | 25.05 Billion TWD | 6.93% |
2023 Q2 | 20.77 Billion TWD | -8.93% |
2023 Q1 | 22.8 Billion TWD | 0.21% |
2023 FY | 25.05 Billion TWD | 10.06% |
2023 Q3 | 23.42 Billion TWD | 12.79% |
2022 Q3 | 23.04 Billion TWD | 0.0% |
2022 Q4 | 22.76 Billion TWD | -1.24% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Grape King Bio Ltd | 15.51 Billion TWD | -61.502% |
Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -123.904% |
Maywufa Company Ltd. | 2.83 Billion TWD | -784.583% |
ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | -113.725% |
Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 24.065% |
LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -2903.215% |
YungShin Global Holding Corporation | 11.51 Billion TWD | -117.608% |
PhytoHealth Corporation | 2.35 Billion TWD | -965.811% |
SCI Pharmtech, Inc. | 6.69 Billion TWD | -274.428% |
Formosa Laboratories, Inc. | 13.63 Billion TWD | -83.717% |
PharmaEssentia Corporation | 27.26 Billion TWD | 8.131% |